Generics for other agents are expected sometime after 2027
Conflict of interest: MH has provided consultancy services to AstraZeneca, Novo Nordisk, Merck & Co., and HoffmanLa Roche with respect to incretin-targeted therapeutics and has received investigator-initiated research grants from Novo Nordisk and Merck & Co
Debut of diabetes was estimated as first-ever prescription for glucose-lowering drug, and diabetes duration at baseline was calculated as the time between diabetes debut until index date
Timing Matters Another crucial factor to consider when consuming coffee with glutathione supplementation is timing
New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones and substituted hydrazides to the dicopper active site